Individualized Pharmaceutical-care for Inpatients With Cancer Pain

University of Chinese Academy Sciences

Status

Unknown

Conditions

Cancer Pain

Treatments

Other: pharmaceutical care

Study type

Interventional

Funder types

Other

Identifiers

NCT03455023

ECCOPG-002

Details and patient eligibility

About

The purpose of the study is to investigate the impact of pharmaceutical care on cancer pain treatment for opioid-tolerant inpatients

Full description

This study is a prospective multicenter randomized controlled study to investigate the impact of pharmaceutical care on cancer pain treatment for opioid-tolerant inpatients.

Enrollment

500 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

Patients aged 18 years or older;
Histologically confirmed solid tumor;
Diagnosed chronic cancer pain;
Opioid-tolerant patients;
Overall survival is expected to be over 3 months;
Karnofsky performance score≥50;
Willing and able to comply with the protocol

Exclusion criteria

Current pregnancy or breastfeeding;
Patients diagnosed with non-cancer pain;
Patients treated with patient-controlled analgesia;
Patients with pathological fracture, gastrointestinal obstruction, severe infection, non-opioid related intractable constipation;
Patients with mental disorder;
Creatinine clearance rate <15mL/min;
ALT or AST ≥ 10 fold of upper limit of normal value